Eventide Healthcare & Life Sciences Fd Cl I Receivables

Eventide Healthcare & Life Sciences Fd Cl I posts a receivables of $590K as of May 2023. That compares with $550K in the prior-year period — up 8.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Eventide Healthcare & Life Sciences Fd Cl I's receivables was $550K. The latest reading is $590K — a 8.8% year-over-year increase (period ending May 2023). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Eventide Healthcare & Life Sciences Fd Cl I's financial statement story. At $590K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ETIHX's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Eventide Healthcare & Life Sciences Fd Cl I's other metric pages and overview cover the third.